Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
The Eye Disease Clinical Medical Research Center of Yunnan Province, Kunming, China.
BMC Ophthalmol. 2021 May 13;21(1):214. doi: 10.1186/s12886-021-01979-3.
Mucopolysaccharidosis type VI (MPS VI) is a rare autosomal recessive inherited disease caused by mutations in the arylsulfatase B (ARSB) gene. MPS VI is a multisystemic disease resulting from a deficiency in arylsulfatase B causing an accumulation of glycosaminoglycans in the tissues and organs of the body. In this report, we present the case of a 16-year-old Chinese male who presented with vision loss caused by corneal opacity. MPS VI was confirmed by genetic diagnosis.
A 16-year-old Chinese male presented with a one-year history of binocular vision loss. The best-corrected visual acuity was 0.25 in the right eye and 0.5 in the left eye. Although slit-lamp examination revealed corneal opacification in both eyes, the ocular examinations of his parents were normal. At the same time, the patient presented with kyphotic deformity, short stature, joint and skeletal malformation, thick lips, long fingers, and coarse facial features. Genetic assessments revealed that ARSB was the causative gene. Compound heterozygous missense mutations were found in the ARSB gene, namely c.1325G > A (p. Thr442Met) (M1) and c.1197G > C (p. Phe399Leu) (M2). Genetic diagnosis confirmed that the patient had MPS VI.
This paper reports a case of MPS VI confirmed by genetic diagnosis. MPS VI is a multisystem metabolic disease, with corneal opacity as a concomitant ocular symptom. As it is difficult for ophthalmologists to definitively diagnose MPS VI, genetic testing is useful for disease confirmation.
黏多糖贮积症 VI 型(MPS VI)是一种罕见的常染色体隐性遗传性疾病,由芳基硫酸酯酶 B(ARSB)基因突变引起。MPS VI 是一种多系统疾病,由于 ARSB 的缺乏导致糖胺聚糖在体内组织和器官中积累。在本报告中,我们报告了一例 16 岁的中国男性,因角膜混浊导致视力丧失。MPS VI 通过基因诊断得到确认。
一名 16 岁的中国男性,因双眼视力丧失一年就诊。最佳矫正视力右眼为 0.25,左眼为 0.5。尽管裂隙灯检查显示双眼角膜混浊,但他父母的眼部检查均正常。同时,患者还存在脊柱后凸畸形、身材矮小、关节和骨骼畸形、嘴唇厚、手指长和粗糙的面部特征。基因评估显示 ARSB 是致病基因。在 ARSB 基因中发现复合杂合错义突变,即 c.1325G>A(p.Thr442Met)(M1)和 c.1197G>C(p.Phe399Leu)(M2)。基因诊断证实患者患有 MPS VI。
本文报告了一例经基因诊断确认的 MPS VI 病例。MPS VI 是一种多系统代谢疾病,角膜混浊是其伴随的眼部症状。由于眼科医生难以明确诊断 MPS VI,因此基因检测有助于疾病的确诊。